What is NEOG EV/EBITDA?

Neogen Corp (NEOG) EV/EBITDA

As of May 31, 2025, Neogen Corp (NEOG) reports a EV/EBITDA of -6.55.

EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.

Comparing Neogen Corp's EV/EBITDA to Peers

To better understand Neogen Corp's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:

Company EV/EBITDA
Neogen Corp (NEOG) -6.55
BioLife Solutions Inc (BLFS) 177.85
Atrion Corp (ATRI) 26.39
Merit Medical Systems Inc (MMSI) 21.06
Meridian Bioscience Inc (VIVO) 17.49
ICU Medical Inc (ICUI) 15.92

Compared to its competitors, Neogen Corp's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.